Skip to search formSkip to main contentSkip to account menu

Antibody-Drug Conjugate DFRF4539A

Known as: ADC DFRF4539A, DFRF4539A 
An antibody-drug conjugate (ADC) composed of a monoclonal antibody directed against a specific myeloma antigen and conjugated to monomethyl… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Phase I study of the anti-FcRH5 antibody-drug conjugate DFRF4539A in relapsed or refractory multiple myeloma
FcRH5 is a cell surface marker enriched on malignant plasma cells when compared to other hematologic malignancies and normal… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)